加拿大安大略省估计 SARS-CoV-2 奥密克戎变异株的严重程度。
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
机构信息
Public Health Ontario, Toronto, Ontario, Canada.
出版信息
JAMA. 2022 Apr 5;327(13):1286-1288. doi: 10.1001/jama.2022.2274.
Abstract
This study examines hospitalizations and deaths associated with the SARS-CoV-2 Omicron variant compared with matched patients infected with the Delta variant.
摘要
这项研究比较了与感染德尔塔变异株的患者相匹配的奥密克戎变异株 SARS-CoV-2 相关的住院和死亡病例。
相似文献
1
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.加拿大安大略省估计 SARS-CoV-2 奥密克戎变异株的严重程度。
JAMA. 2022 Apr 5;327(13):1286-1288. doi: 10.1001/jama.2022.2274.
2
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.加拿大安大略省的新冠病毒奥密克戎变种毒株的严重程度
JAMA. 2022 Jul 26;328(4):395. doi: 10.1001/jama.2022.9259.
3
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.加拿大安大略省的严重急性呼吸综合征冠状病毒2型奥密克戎变种的严重程度——回复
JAMA. 2022 Jul 26;328(4):395-396. doi: 10.1001/jama.2022.9262.
4
Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada.基于先前 SARS-CoV-2 污水负荷的奥密克戎 COVID-19 病例估计，加拿大安大略省皮尔地区。
Emerg Infect Dis. 2023 Aug;29(8):1580-1588. doi: 10.3201/eid2908.221580. Epub 2023 Jun 28.
5
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada.加拿大安大略省护理院和退休之家居民对奥密克戎感染的防护。
J Am Med Dir Assoc. 2023 May;24(5):753-758. doi: 10.1016/j.jamda.2023.02.105. Epub 2023 Mar 28.
6
SARS-CoV-2 viral titer measurements in Ontario, Canada wastewaters throughout the COVID-19 pandemic.加拿大安大略省新冠疫情期间废水中的 SARS-CoV-2 病毒滴度测量。
Sci Data. 2024 Jun 21;11(1):656. doi: 10.1038/s41597-024-03414-w.
7
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.奥密克戎或德尔塔变异株感染及重症的 COVID-19 疫苗有效性评估。
JAMA Netw Open. 2022 Sep 1;5(9):e2232760. doi: 10.1001/jamanetworkopen.2022.32760.
8
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.2021 年 5 月至 2022 年 1 月期间，加拿大安大略省青少年和儿科 SARS-CoV-2 病例住院疫苗有效性：一项回顾性队列研究。
PLoS One. 2023 Mar 31;18(3):e0283715. doi: 10.1371/journal.pone.0283715. eCollection 2023.
9
SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.2020 年 1 月至 2022 年 1 月期间加拿大艾伯塔省、不列颠哥伦比亚省和安大略省的 SARS-CoV-2 传播情况。
Emerg Infect Dis. 2024 May;30(5):956-967. doi: 10.3201/eid3005.230482.
10
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
引用本文的文献
1
Impact of vaccination and SARS-CoV-2 variants on severe COVID-19 outcomes: a cross-sectional study, Brazil, 2021-2022.疫苗接种和新冠病毒变异株对重症新冠肺炎结局的影响：一项横断面研究，巴西，2021 - 2022年
Epidemiol Serv Saude. 2025 Sep 1;34:e20240613. doi: 10.1590/S2237-96222025v34e20240613.en. eCollection 2025.
2
Examining epidemiologic disparity across SARS-CoV-2 variant-dominant periods in Oklahoma County, Oklahoma (March 12, 2020-February 28, 2022).研究俄克拉何马州俄克拉何马县在新冠病毒变异株主导时期（2020年3月12日至2022年2月28日）的流行病学差异。
J Public Health Res. 2025 Aug 10;14(3):22799036251363919. doi: 10.1177/22799036251363919. eCollection 2025 Jul.
3
In-hospital mortality in patients admitted to Australian intensive care units with COVID-19 between 2020 and 2024.2020年至2024年期间，入住澳大利亚重症监护病房的新冠肺炎患者的院内死亡率。
Crit Care Resusc. 2025 Feb 28;27(1):100094. doi: 10.1016/j.ccrj.2024.11.003. eCollection 2025 Mar.
4
Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.孟加拉国不同新冠病毒变异株患者的临床特征、治疗结果及病死率风险
J Glob Health. 2024 Jun 21;14:05009. doi: 10.7189/jogh.14.05009.
5
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024.2019冠状病毒病疫苗对成人严重急性呼吸综合征冠状病毒2感染及严重后果的有效性：截至2024年1月22日发表的欧洲研究的系统评价和荟萃分析
Eur Respir Rev. 2025 Feb 19;34(175). doi: 10.1183/16000617.0222-2024. Print 2025 Jan.
6
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations.重症 COVID-19 疾病与影响血浆 ACE2 受体和 CRP 浓度的遗传因素有关。
Sci Rep. 2025 Feb 8;15(1):4708. doi: 10.1038/s41598-025-89306-4.
7
Cardiac Damage in Patients Infected with Different SARS-CoV-2 Variants of Concern.感染不同关注的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株患者的心脏损伤
Microorganisms. 2024 Dec 18;12(12):2617. doi: 10.3390/microorganisms12122617.
8
Vulnerability: An Interpretive Descriptive Study of Personal Support Workers' Experiences of Working During the COVID-19 Pandemic in Ontario, Canada.脆弱性：对加拿大安大略省个人支持工作者在新冠疫情期间工作经历的解释性描述性研究
Healthcare (Basel). 2024 Dec 6;12(23):2474. doi: 10.3390/healthcare12232474.
9
Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey.奥密克戎感染和疫苗接种在儿科肝移植受者中的临床结局：来自横断面调查的见解。
Virol J. 2024 Nov 22;21(1):299. doi: 10.1186/s12985-024-02531-7.
10
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant.奥密克戎变异株出现前后，喉咙痛与针对新冠病毒的早期免疫反应之间的关联。
Ann Transl Med. 2024 Oct 20;12(5):87. doi: 10.21037/atm-24-36. Epub 2024 Sep 19.
本文引用的文献
1
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.苏格兰关注的奥密克戎变异株的严重程度和疫苗加强针预防有症状疾病的效果（EAVE II）：一项具有巢式病例对照研究设计的全国队列研究。
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
2
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.南非对 SARS-CoV-2 奥密克戎变异株临床严重程度的早期评估：一项数据关联研究。
Lancet. 2022 Jan 29;399(10323):437-446. doi: 10.1016/S0140-6736(22)00017-4. Epub 2022 Jan 19.
3
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.SARS-CoV-2 奥密克戎变异株：刺突蛋白-ACE2 复合物的抗体逃逸和冷冻电镜结构。
Science. 2022 Feb 18;375(6582):760-764. doi: 10.1126/science.abn7760. Epub 2022 Jan 20.
4
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.南非在 COVID-19 奥密克戎变异株流行期间住院患者的特征和结局与前几波相比。
JAMA. 2022 Feb 8;327(6):583-584. doi: 10.1001/jama.2021.24868.
Zotero 插件